P2RX7 and neurodegenerative disease: The pathogenic role of P2RX7 in MS progression (and neurodegeneration in general) is also supported by P2RX7 genetic polymorphism (47–49), where gain-of-function variants are observed at higher frequencies and hypomorphic variants at lower frequencies in different neurodegenerative diseases but also in faster aging (50).